molecules (MHC Class I and MHC Class II) with different tissue dis$
Dr M.R. Clark
mrc7 at cus.cam.ac.uk
Thu Oct 6 05:02:48 EST 1994
In article <4OCT94.08384871 at msdisk.wustl.edu>,
<w95_cook at msdisk.wustl.edu> wrote:
>In a previous article, mrc7 at cus.cam.ac.uk (Dr M.R. Clark) wrote:
[lots deleted]
>>Well an obvious reason not to have one type of MHC which presents both
>>endogenous and exogenous antigens is that the T-cell recognising the
>>MHC+peptide wouldn't be able to tell whether the antigen was exogenous or
>>endogenous!
>>Or am I missing something in your question? :-)
>> _
>
>I think you're on the wrong track here. T cells don't discriminate peptides
>as being endogenous or exogenous. They discriminate self from non-self, but
>even that is maintained through tolerance induction and does not strictly
>depend on which MHC molecule is involved in binding.
[rest deleted]
>
>Jim Cook
>
Yes I agree with your message that there is a primary role to allow for
different profiles of response and the possibility of help and cooperation
between primed and unprimed T-cells.
I guess my reply to the earlier messages was very brief and that is always
dangerous when discussing complex issues. However although it is
semantically incorrect to imply that T-cells "know" the difference what
I was trying to point out was that the system as a whole allows for peptides
to be processed and presented in two different ways (and for the antigens)
to be aquired in two different ways.
These antigens are then presented to T-cells which represent
different selected sub-populations of lymphocytes which as the rest of
your message points out interact with each other in a complex way.
But the point is if there were only one type of MHC molecule it would be
very difficult to set up such a complex system
o/ \\ // || ,_ o Mike Clark, mrc7 at cus.cam.ac.uk
<\__,\\ // __o || / /\, Cambridge University, Dept. Pathology
"> || _`\<,_ // \\ \> | "to pay for my hobbies I have to work
` || (_)/ (_) // \\ \_ as an antibody engineer"
More information about the Immuno
mailing list